抗HIV治療ガイドライン（2024年3月発行）

XIV急性HIV感染症とその治療

文献

  1. Cohen MS, Shaw GM, McMichael AJ, et al. Acute HIV-1 Infection. N Engl J Med. 364: 1943-54, 2011.
  2. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (米国DHHS, Feb 27,2024).
    https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new
  3. Gandhi RT, Bedimo R, Hoy JF, et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. JAMA.2022 Dec 1. doi: 10.1001/jama.2022.22246
  4. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2023 interim update). https://www.bhiva.org/HIV-1-treatment-guidelines
  5. European AIDS clinical society (EACS) guidelines (Version 12.0, October 2023). https://eacs.sanfordguide.com
  6. Principles and practice of Infectious Disease. Mandell, Douglas, and Bennett’s 9th edition, 1659-60, 2019.
  7. Chu C and Selwyn PA. Diagnosis and initial management of acute HIV infection. Am Fam Physician. 81: 1239-44, 2010.
  8. 診療におけるHIV-1/2感染症の診断ガイドライン2020版, 日本エイズ学会・日本臨床検査医学会標準推奨法 https://jaids.jp/wpsystem/wp-content/uploads/2020/10/guidelines.pdf
  9. Kondo M, Sudo K, Sano T, et al. Comparative evaluation of the Geenius HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population. PLoS ONE 13: e0198924, 2018.
  10. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-70, 1996.
  11. Ananworanich J, Chomont N, Eller LA, et al. HIV DNA set point is rapidly established in acute HIV infection and dramatically reduced by early ART. EBioMedicine. 11: 68-72, 2016.
  12. Strain MC, Little SJ, Daar ES, et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 191: 1410-1418, 2005.
  13. Muscatello A, Nozza S, Fabbiani M et al. Inaction Study Group. Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection-results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. Pathog Immun. 5: 8–33, 2020
  14. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 373: 795-807, 2015.
  15. TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 373: 808-22, 2015.
  16. Cohen MS, Chen YQ, McCauley M, et al.; HPTN 052 Study Team. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 375: 830-9, 2016.
  17. Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 393: 2428-2438, 2019.
  18. 菊地正、西澤雅子、小島潮子ら. 2022年の国内新規診断未治療HIV感染者・AIDS患者における薬剤耐性HIV-1の動向. 第37回日本エイズ学会学術集会・総会、抄録番号O15-4.　日本エイズ学会誌. 25: 243, 2023.
  19. HIV薬剤耐性検査ガイドライン ver, 10 （平成28年度 日本医療研究開発機構 エイズ対策実用化研究事業「国内流行HIV及びその薬剤耐性株の長期的動向把握に関する研究」班）https://www.hiv-resistance.jp/resistance04.htm
  20. Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med. 379: 979-81, 2018.
  21. Zash R, Holmes LB, Diseko M, et al. Update on neural tube defects with antiretroviral exposure in the Tsepamo study, Botswana. Poster presented at: 11th IAS Conference on HIV Science; July 18-21, 2021.
  22. Kouris AP, Zhu W, Lampe MA, et al. Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008-20: a national cohort study. Lancet HIV. 10: e588-e596, 2023.
  23. Lockman S, Brummel SS, Ziemba L, et al. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet 397:1276-1292, 2021.
  24. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. (米国DHHS, Jan 31,2024).
    https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new

PAGE TOP